Full-Time

Regional Business Director

Auvelity

Confirmed live in the last 24 hours

Axsome Therapeutics Inc

Axsome Therapeutics Inc

201-500 employees

Develops therapies for CNS disorders

Biotechnology
Healthcare

Compensation Overview

$170k - $205kAnnually

+ Bonus + Equity

Senior

Syracuse, NY, USA

Must live within the territory’s geography.

Category
Field Sales
Sales & Account Management
Required Skills
Sales
Requirements
  • BA or BS required. Advanced degree preferred
  • 5 years or more of field leadership experience and/or payer account management and/or demonstrated sales success with increasing responsibility and organizational leadership
  • Previous pharmaceutical, biotech, or medical marketing/sales experience preferred with at least three to five years spent in a position with demonstrated 1st line leadership groups
  • Proven performance history in the ability to lead others to success through your coaching influence
  • Demonstrated experience delivering outstanding results and developing others to their potential
  • Proven track record in attracting and retaining top talent
  • Current or recent Psychiatry disease experience strongly preferred
  • Successful launch experience strongly preferred
  • Experience to strategize within teams using differential resources to reach business goals
  • Proven ability to run multiple tasks concurrently under aggressive timelines in a dynamic environment
  • Must live within the territory’s geography
  • Comfortable with uncertainty and high expectations
  • Patient support services experience a plus
  • Strong digital marketing aptitude
  • Strong interpersonal and presentation skills
Responsibilities
  • Responsible for supervising operations of the Region which includes: driving results, hiring and coaching, account manager development, performance management, and the assignment of key "priority" accounts within the medical community
  • Develop and implement strategic plans for the Region including the right balance of live/virtual interactions and the prioritization of efforts by the team
  • Plan, organize and drive performance to achieve the business potential of the region through coaching and influence of direct reports
  • Establish and maintain effective communication among all members of the Region across cross-channel stakeholders in the Accounts and Market Access team
  • Maintain required technical expertise in order to respond accurately to all questions regarding products, marketing, policies, and business-related issues from customers and account managers
  • Work with direct reports to understand and consistently execute established expectations.
  • Consistently exemplify the ability to help a SAM improve on their selling skills, product knowledge and capabilities needed for success through coaching and counsel. Lead by example through coaching direct reports both in live and virtual engagements.
  • Effectively plan and conduct plan of action and other meetings with members of the Region and Market Access teams
  • Develop and implement Region business plan, manage Region budget and overall responsibility for P&L at Region level in alignment with Regional and National expectations
  • Have a complete understanding of all relevant compliance laws, policies and processes and ensure actions of self and team are fully compliant
  • Overnight travel as indicated by the needs of the business
  • Additional responsibilities as assigned
Axsome Therapeutics Inc

Axsome Therapeutics Inc

View

Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain to help regulate mood. This drug has shown positive results in clinical trials and has received FDA Breakthrough Therapy Designation, which helps speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.

Company Stage

IPO

Total Funding

$430.7M

Headquarters

New York City, New York

Founded

2012

Growth & Insights
Headcount

6 month growth

3%

1 year growth

3%

2 year growth

3%
Simplify Jobs

Simplify's Take

What believers are saying

  • The launch of Auvelity and the promising results of AXS-12 in Phase 3 trials indicate strong potential for revenue growth and market impact.
  • Axsome's strategic expansion of its sales force to support Auvelity's launch demonstrates its commitment to commercial success.
  • The appointment of experienced leaders like Dr. Sue Mahony to the board enhances Axsome's strategic direction and governance.

What critics are saying

  • The biopharmaceutical sector's inherent risks, including regulatory hurdles and clinical trial failures, could impact Axsome's progress.
  • High competition in the CNS disorder treatment market may challenge Axsome's ability to capture significant market share.

What makes Axsome Therapeutics Inc unique

  • Axsome Therapeutics focuses on CNS disorders with a strong emphasis on unmet medical needs, setting it apart from broader biopharmaceutical companies.
  • The FDA Breakthrough Therapy Designation for AXS-05 highlights its innovative approach and potential for rapid market entry.
  • Axsome's diversified pipeline, including treatments for MDD, TRD, Alzheimer's agitation, and narcolepsy, showcases its comprehensive strategy in CNS therapeutics.

Help us improve and share your feedback! Did you find this helpful?